Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas (2013)

  • Authors:
  • USP affiliated authors: SOARES, FERNANDO AUGUSTO - FO ; SILVA, ALFREDO RIBEIRO DA - FMRP
  • USP Schools: FO; FMRP
  • DOI: 10.1186/1746-1596-8-170
  • Subjects: ADENOCARCINOMA; NEOPLASIAS PANCREÁTICAS (PATOLOGIA); IMUNOHISTOQUÍMICA; MICROANÁLISE; PROGNÓSTICO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/1746-1596-8-170 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    • Licença: cc-by
    Informações sobre o Citescore
  • Título: Diagnostic Pathology

    ISSN: 1746-1596

    Citescore - 2017: 2.13

    SJR - 2017: 0.818

    SNIP - 2017: 0.983


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2476762pcd 2476762 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ZORGETTO, Verônica Assalin; SILVEIRA, Giórgia Gobbi da; COSTA, João Paulo Oliveira; et al. The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas. Diagnostic Pathology, London, v. 8, 2013. Disponível em: < http://dx.doi.org/10.1186/1746-1596-8-170 > DOI: 10.1186/1746-1596-8-170.
    • APA

      Zorgetto, V. A., Silveira, G. G. da, Costa, J. P. O., Soave, D. F., Soares, F. A., & Ribeiro-Silva, A. (2013). The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas. Diagnostic Pathology, 8. doi:10.1186/1746-1596-8-170
    • NLM

      Zorgetto VA, Silveira GG da, Costa JPO, Soave DF, Soares FA, Ribeiro-Silva A. The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas [Internet]. Diagnostic Pathology. 2013 ; 8Available from: http://dx.doi.org/10.1186/1746-1596-8-170
    • Vancouver

      Zorgetto VA, Silveira GG da, Costa JPO, Soave DF, Soares FA, Ribeiro-Silva A. The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas [Internet]. Diagnostic Pathology. 2013 ; 8Available from: http://dx.doi.org/10.1186/1746-1596-8-170

    Referências citadas na obra
    Bevan R, Young C, Holmes P, Fortunato L, Slack R, Rushton L: Occupational cancer in Britain. Gastrointestinal cancers: liver, oesophagus, pancreas and stomach. Br J Cancer 2012, 107:S33--S40.
    Vainio H: Targeting angiogenesis – a novel mode in cancer chemoprevention. Asian Pacific J Cancer Prev 2003, 4:83–86.
    Alitalo A, Detmar M: Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 2012, 31:4499–4508.
    Nagy JA, Dvorak AM, Dvorak HF: VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis 2007, 2:251–275.
    Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S: Anti-VEFG-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. Int J Cancer 2007, 121:2182–2191.
    Christiansen A, Detmar M: Lymphangiogenesis and Cancer. Genes Cancer 2011, 2:1146–1158.
    Zhang LZ, Zhang CQ, Yan ZY, Yang QC, Jiang Y, Zeng BF: Tumor-initiating cells and tumor vascularization. Pediatr Blood Cancer 2011,56(3):335–340.
    Lin M, Ma SP, Lin HZ, Ji P, Xie D, Yu JX: Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis 2010,27(3):123–132.
    Leong SP, Nakamura EK, Pollok R, Choti MA, Morton DL, Henner WD, Lal A, Pillai R, Clark OH, Cady B: Unique patterns of metastases in common and rare types of malignancy. J Surg Oncol 2011,103(6):607–614.
    Sharma RA, Harris AL, Dalgleish AG, Steward WP, O’Byrne KJ: Angiogenesis as a biomarker and target in cancer chemoprevention. Lancet Oncol 2001,2(12):726–732.
    Kysas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D: Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005,206(2):170–177.
    Kayser K, Schultz H, Goldmann T, Görtler J, Kayser G, Vollmer E: Theory of sampling and its application in tissue based diagnosis. Diagn Pathol 2009, 4:6.
    Santini D, Vicenzi B, Perrone G, Rabitti C, Borzomati D, Valeri S, Coppola R, Magistrelli P, Tonini G: Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. Ann Oncol 2005,16(11):1847–1848.
    Smith RA, Tang J, Tudur-Smith C, Neoptolemos JP, Ghaneh P: Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer 2011,104(9):1440–1451.
    Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 1991,324(1):1–8.
    Alexiev BA, Drachenberg CB, Papadimitriou JC: Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior. Diagn Pathol 2007, 2:28.
    Yeo TP, Lowenfels AB: Demographics and epidemiology of pancreatic cancer. The Cancer Journal 2012,18(6):477–484.
    Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green M, Cozen W, Cockburn M, Sibug Saber M, Topor M, Zeruto C, Abedi-Ardekani B, Reichman ME, Hewitt SM: Associations between selected biomarkers and prognosis in a populations-based pancreatic cancer tissue microarray. Cancer Res 2009,69(7):2950–2955.
    Hidalgo M: Pancreatic cancer. N Engl J Med 2010, 362:1605–1617.
    Klöppel G, Hrubau RH, Longnecker DS, Adler G, Kern SE, Partanen TJ: Ductal Adenocarcinoma of the Pancreas. In Pathology and Genetics of Tumours of the Digestive System. Edited by: Hamilton SR, Aaltonen LA. Lyon: ARC Press; 2000:221–230.
    Lins TC, Vieira RG, Abreu BS, Gentil P, Moreno-Lima R, Oliveira RJ, Pereira RW: Genetic heterogeneity of self-reported ancestry groups in an admixed Brazilian population. J Epidemiol 2011,21(4):240–245.
    Oliveira LR, Jeffrey SS, Ribeiro-Silva A: Stem cells in human breast cancer. Histol Histopathol 2010,25(3):371–385.
    Braun S, Bitton-Worms K, LeRoith D: The link between the metabolic syndrome and cancer. Int J Biol Sci 2011,7(7):1003–1015.
    Li D: Diabetes and pancreatic cancer. Mol Carcinog 2012,51(1):64–74.
    Prizment AE, Gross M, Rasmussen-Torvik L, Peacock JM, Anderson KE: Genes related to diabetes may be associated with pancreatic cancer in a population-based case–control study in Minnesota. Pancreas 2012,41(1):50–53.
    Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, et al.: Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 2013,24(1):13–25.
    Kayser K, Nwoye JO, Kosjerina Z, Goldmann T, Vollmer E, Kaltner H, André S, Gabius HJ: Atypical adenomatous hyperplasia of lung: its incidence and analysis of clinical, glycohistochemical and structural features including newly defined growth regulators and vascularization. Lung Cancer 2003,42(2):171–182.
    Kawauchi S, Fukuda T, Tsuneyoshi M: Angiogenesis does not correlate with prognosis or vascular endothelial growth factor in synovial sarcomas. Oncol Rep 1999,6(5):959–1023.
    Sullu Y, Gun S, Atmaca S, Karagoz F, Kandemir B: Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. Diagn Pathol 2010, 5:35.
    Kayser G, Baumhäkel JD, Szöke T, Trojan I, Riede U, Werner M, Kayser K: Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch 2003,442(5):462–467.
    Sleeman JP, Thiele W: Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009,125(12):2747–2756.
    Sleeman JP, Schmid A, Thiele W: Tumor lymphatics. Semin Cancer Biol 2009,19(5):285–297.
    Rubbia-Brandt L, Terris B, Giostra E, Dousset B, Morel P, Pepper MS: Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res 2004,10(20):6919–6928.
    Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Keriaschki D, Klöppel G: Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 2005,207(3):301–312.
    Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathinsen D, Wain J, Mark EJ, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002,296(5574):1883–1886.
    Schopmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Cauciq C, Kriehuber E, Nagy K, Alitalo K, Keriaschki D: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002,161(3):947–956.
    Yin N, Zhang N, Lal G, Xu J, Yan M, Ding Y, Bromberg JS: Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. PLoS One 2011,6(11):e28023.
    Wang Z, Wu J, Li G, Zhang X, Tong M, Wu Z, Lui Z: Lymphangiogenesis and biological behavior in pancreatic carcinoma and other pancreatic tumors. Mol Med Rep 2012,5(4):959–963.
    Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000,21(3):505–515.
    Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002,29(6 Suppl 16):15–18.
    Folkman J: Angiogenesis. Annu Rev Med 2006, 57:1–18.
    Cao Y, Langer R: A review of Judah Folkman’s remarkable achievements in biomedicine. Proc Natl Acad Sci U S A 2008,105(36):13203–13205.
    Otrock ZK, Makarem JA, Shamseddine AI: Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007,38(3):258–268.
    Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO: Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 2008,121(Pt 20):3487–3495.
    Woolard J, Bevan HS, Harper SJ, Bates DO: Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation 2009,16(7):572–592.
    Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, Nagy JA, Dvorak HF, Ylä-Herrttuala S, Shibuya M, Alitalo K: Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 2007,204(6):1431–1440.
    Liang QL, Wang BR, Chen GQ, Li GH, Xu YY: Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters. Med Oncol 2010,27(4):1164–1170.
    Cao Y: Why and how do tumors stimulate lymphangiogenesis? Lymphat Res Biol 2008,6(3–4):145–148.